We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cyclooxygenase 2, toll-like receptor 4 and interleukin 1β mRNA expression in atherosclerotic plaques of type 2 diabetic patients.
- Authors
Baldan, Alessandro; Ferronato, Silvia; Olivato, Silvia; Malerba, Giovanni; Scuro, Alberto; Veraldi, Gian; Gelati, Matteo; Ferrari, Sergio; Mariotto, Sara; Pignatti, Pier; Mazzucco, Sara; Gomez-Lira, Macarena
- Abstract
Objectives and design: Inflammation has a prominent role in the development of atherosclerosis. Type 2 diabetes could contribute to atherosclerosis development by promoting inflammation. This status might accelerate changes in intrinsic vascular wall cells and favor plaque formation. Cyclooxygenase 2 (COX-2) is highly expressed in atherosclerotic plaques. COX-2 gene expression is promoted through activation of toll-like receptor 4 (TLR4) and pro-inflammatory cytokine interleukin 1β (IL1-β). Aim of this study is to investigate whether expression profiles of pro-inflammatory genes such as COX-2, TLR4 and IL1-β in atherosclerotic plaques are altered in type 2 diabetes (T2D). Methods: Total RNA was isolated from plaques of atherosclerotic patients and expression of COX-2, TLR4, IL1-β analyzed using real-time PCR. Histological analysis was performed on sections of the plaque to establish the degree of instability. Results: Statistically significant differences in mRNA expression of COX-2 and IL1-β were found in plaques of T2D compared with non-T2D patients. A multi-variable linear regression model suggests that COX-2 mRNA expression is affected by T2D pathology and IL1-β mRNA expression in atherosclerotic plaques. Conclusions: Our results support the hypothesis that T2D pathology contributes in vivo to increase the inflammatory process associated with the atherosclerotic plaque formation, as shown by an increment of COX-2 and IL1-β mRNA expression.
- Subjects
CYCLOOXYGENASE 2; INTERLEUKIN-1; MESSENGER RNA; ATHEROSCLEROTIC plaque; PEOPLE with diabetes; PATIENTS
- Publication
Inflammation Research, 2014, Vol 63, Issue 10, p851
- ISSN
1023-3830
- Publication type
Article
- DOI
10.1007/s00011-014-0759-8